Therapeutic Dose of Mirtazapine for Anxiety
Start mirtazapine at 15 mg once daily at bedtime, and titrate up to 30-45 mg daily based on response, with dose changes made no more frequently than every 1-2 weeks. 1
Dosing Algorithm
Initial Dosing
- Starting dose: 15 mg at bedtime 1
- The FDA-approved starting dose for depression is 15 mg daily, preferably in the evening prior to sleep
- Some guidelines suggest starting at 7.5 mg at bedtime for elderly or sensitive patients 2
Titration Schedule
- Increase dose in 15 mg increments every 1-2 weeks as tolerated 1
- Do not make dose changes more frequently than 1-2 week intervals to allow adequate time to assess response
- Maximum dose: 45 mg daily 1
Target Therapeutic Range
- 30-45 mg daily appears most effective for anxiety based on research evidence 3, 4
- Studies specifically examining anxiety disorders used fixed doses of 30 mg 4, 5 or 30-45 mg 3
- The 15 mg dose may be subtherapeutic for anxiety, though it provides sedative benefits
Evidence-Based Considerations
Efficacy Profile
The evidence for mirtazapine in anxiety is mixed but shows promise in specific contexts:
In Major Depressive Disorder with anxiety symptoms: Mirtazapine demonstrates early-onset anxiolytic effects (within 1-2 weeks) and may outperform SSRIs for anxiety symptoms 6, 7. This is particularly true for patients with severe baseline anxiety (GAD-7 ≥16) 7
In Generalized Anxiety Disorder: Open-label studies at 30 mg showed 79.5% response rates 4, but a controlled trial at 30-45 mg failed to separate from placebo 3. This suggests mirtazapine may serve as an alternative when first-line agents fail, but is not established as first-line monotherapy
In Panic Disorder: Open-label data at 30 mg daily showed significant improvement in panic attacks and anticipatory anxiety 5
Unique Advantages
Mirtazapine offers several benefits that may be particularly valuable for anxious patients:
- Rapid onset: Anxiolytic effects may appear within 1-2 weeks, faster than typical SSRIs 6
- Sleep improvement: Sedating properties help with insomnia commonly comorbid with anxiety 8, 9
- Appetite stimulation: Beneficial when anxiety causes anorexia 9
- No sexual dysfunction: Unlike SSRIs, avoiding a common treatment-limiting side effect
Clinical Pitfalls and Caveats
Common Adverse Effects
- Somnolence is the most frequent side effect 6
- Weight gain and increased appetite 2
- These effects are dose-dependent and may actually be therapeutic in patients with insomnia and poor appetite
Drug Interactions Requiring Dose Adjustment
- Strong CYP3A4 inducers (carbamazepine, phenytoin, rifampin): May require dose increase; these can reduce mirtazapine levels by ~60% 1
- Strong CYP3A4 inhibitors (ketoconazole, clarithromycin): May require dose reduction; can increase mirtazapine levels by 40-50% 1
- Cimetidine: Increases mirtazapine AUC by >50%; consider dose reduction 1
Special Populations
- Renal impairment: No specific dose adjustment required, but monitor closely
- Elderly patients: Consider starting at 7.5 mg and titrating more cautiously 2
- Cardiovascular disease: Mirtazapine appears safe and may be preferred over TCAs 8
Discontinuation
- Taper gradually rather than stopping abruptly to minimize withdrawal symptoms 1
- Reduce dose over 10-14 days when discontinuing 2
When to Consider Mirtazapine for Anxiety
Best candidates:
- Depression with prominent anxiety symptoms, especially severe anxiety 7
- Anxiety with comorbid insomnia or poor appetite 8, 9
- Patients who cannot tolerate SSRIs due to activation, sexual dysfunction, or GI effects
- Treatment-resistant anxiety as augmentation or alternative strategy 10
Less optimal scenarios:
- First-line monotherapy for GAD (SSRIs/SNRIs preferred) 3
- Patients concerned about weight gain or sedation
- When alertness is critical (due to sedating effects)